Xeris Pharmaceuticals (XERS)
(Delayed Data from NSDQ)
$1.75 USD
+0.05 (2.94%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.75 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Earnings News For XERS
-
Xeris Biopharma: Q4 Earnings Snapshot
-
Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
-
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
-
Xeris Biopharma: Q3 Earnings Snapshot
-
Xeris Biopharma Reports Third Quarter 2023 Financial Results
-
Xeris Biopharma: Q2 Earnings Snapshot
-
Xeris Biopharma Reports Second Quarter 2023 Financial Results
-
Xeris Biopharma: Q1 Earnings Snapshot
-
Xeris Biopharma Reports First Quarter 2023 Financial Results
-
Xeris Biopharma: Q4 Earnings Snapshot
-
Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
-
Xeris Biopharma: Q3 Earnings Snapshot
-
Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events
-
Xeris Biopharma (XERS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Xeris Biopharma: Q2 Earnings Snapshot
-
Xeris Biopharma Reports Second Quarter Financial Results and Upcoming Events
-
Xeris Biopharma (XERS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Will Xeris Biopharma (XERS) Report Negative Q3 Earnings? What You Should Know
-
Xeris Pharmaceuticals (XERS) Reports Q2 Loss, Misses Revenue Estimates
-
Xeris Pharmaceuticals (XERS) Reports Q1 Loss, Tops Revenue Estimates
-
Xeris Pharmaceuticals (XERS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Xeris Pharmaceuticals (XERS) Reports Q4 Loss, Misses Revenue Estimates
-
Xeris Pharmaceuticals (XERS) Reports Q3 Loss, Tops Revenue Estimates
-
Xeris Pharmaceuticals (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Xeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Lags Revenue Estimates